Prostaglandin I(2) analogues enhance already exuberant Th17 cell responses in systemic sclerosis
Published inAnnals of the rheumatic diseases, vol. 71, no. 12, p. 2044-2050
Publication date2012
Abstract
Keywords
- Adaptive Immunity/drug effects/immunology
- Adult
- Aged
- Aged, 80 and over
- Antihypertensive Agents/pharmacology
- Cell Proliferation/drug effects
- Cells, Cultured
- Cyclic AMP-Dependent Protein Kinases/metabolism
- Epoprostenol/analogs & derivatives/pharmacology
- Female
- Humans
- Iloprost/pharmacology
- Interferon-gamma/metabolism
- Interleukin-17/metabolism
- Interleukin-23 Subunit p19/metabolism
- Interleukins/metabolism
- Male
- Middle Aged
- Monocytes/drug effects/immunology/metabolism
- Platelet Aggregation Inhibitors/pharmacology
- Scleroderma, Systemic/drug therapy/immunology
- Th1 Cells/drug effects/immunology/metabolism
- Th17 Cells/drug effects/immunology/metabolism
- Young Adult
Research groups
Citation (ISO format)
TRUCHETET, Marie-Elise et al. Prostaglandin I(2) analogues enhance already exuberant Th17 cell responses in systemic sclerosis. In: Annals of the rheumatic diseases, 2012, vol. 71, n° 12, p. 2044–2050. doi: 10.1136/annrheumdis-2012-201400
Main files (1)
Article (Published version)
Identifiers
- PID : unige:27786
- DOI : 10.1136/annrheumdis-2012-201400
- PMID : 22814427
Journal ISSN0003-4967
